Biomea Fusion Inc is a preclinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BMEA is expected to report earnings to -91 cents per share on March 31
Q4'24
Est.
$-0.91
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.05
Q1'24
Missed
by $0.10
Q4'23
Missed
by $0.13
The last earnings report on October 29 showed earnings per share of -91 cents, beating the estimate of -93 cents. With 1.22M shares outstanding, the current market capitalization sits at 72.11M.